Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease.

Hammami I. et al, (2025), Heart

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Mitchell J. et al, (2025), Nat Commun, 16

Polygenic prediction of coronary artery disease among 130,000 Mexican adults

EMBERSON J. et al, (2025)

Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis.

Wen S. et al, (2025), Nat Genet

Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)

Horby PW. et al, (2025)

Author Correction: A deep catalogue of protein-coding variation in 983,578 individuals.

Sun KY. et al, (2025), Nature, 637

Cognitive impairment at older ages among 8000 men and women living in Mexico City: a cross-sectional analyses of a prospective study.

González-Carballo C. et al, (2024), BMC Public Health, 24

Abstract 4113475: Association of Age at Diabetes Diagnosis and All-cause and Cardiovascular Mortality among 600,000 US Adults

Thomson B. et al, (2024), Circulation, 150, a4113475 - a4113475

Alcohol and mortality in Mexico: prospective study of 150 000 adults.

Trichia E. et al, (2024), Lancet Public Health, 9, e907 - e915

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

EMPA-KIDNEY Collaborative Group None. et al, (2024), N Engl J Med

Blood Pressure, eGFR, and Kidney Mortality in Mexico: A Prospective Study of 150,000 Adults

Zhu D., (2024)

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Mayne KJ. et al, (2024), Nephrol Dial Transplant

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2024)

Design, recruitment and baseline characteristics of the LENS trial.

LENS Collaborative Group None., (2024), Diabet Med, 41

Associations of fruit intake with adiposity and cardiometabolic biomarkers in UK Biobank.

Trichia E. et al, (2024), BMC Public Health, 24

A deep catalogue of protein-coding variation in 983,578 individuals.

Sun KY. et al, (2024), Nature, 631, 583 - 592

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Mayne KJ. et al, (2024), Clin J Am Soc Nephrol, 19, 1119 - 1129

Effect of Fenofibrate on Progression of Diabetic Retinopathy.

Preiss D. et al, (2024), NEJM Evid

Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Mitchell J. et al, (2024)

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319

Load More